Diffusion Tensor Imaging Evaluates Effects of Acupoint Injection at Zusanli (ST36) for Type 2 Diabetic Peripheral Neuropathy

29 June 2022: Clinical Research

Yangkui Zhai ^1CEG* , Wenjuan Yu ^2ACE* , Wen Shen ^3E* , Yan Zhang ^4E

DOI: 10.12659/MSM.935979

Med Sci Monit 2022; 28:e935979

Table 1 Demographic and baseline characteristics.

Group	Acupoint injection	Intramuscular injection	P value
Age (years)	49.22±5.24	51.58±5.66	0.13
Male, n (%)	49%	38%	0.14
BMI index (kg/m)	23.17±3.19	24.41±2.69	1.01
FBG (mmol/L)	7.81±2.11	8.24±2.14	0.63
Hb (%)	8.12±2.22	8.54±2.41	0.52
Case of DR	8 (20)	10 (20)	0.46
UACR (mg/g)	16.1±2.15	14.4±2.88	0.21
BMI – body max index; FBG – fasting blood glucose; Hb – glycated hemoglobin; DR – diabetic retinopathy; UACR – urine albumin-creatine ratio.